Common Contracts
6 similar Severance and Change of Control Agreement contracts by CytomX Therapeutics, Inc.
Severance and Change of Control AgreementSeverance and Change of Control Agreement • August 8th, 2018 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of May 16, 2018 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Lloyd Rowland (“Employee”).
Severance and Change of Control AgreementSeverance and Change of Control Agreement • August 7th, 2017 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of May 15, 2017 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Debanjan Ray (“Employee”).
Severance and Change of Control AgreementSeverance and Change of Control Agreement • March 2nd, 2017 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Michael Kavanaugh, Senior Vice President, Chief Scientific Officer (“Employee”).
Severance and Change of Control AgreementSeverance and Change of Control Agreement • March 2nd, 2017 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Bob Goeltz, Senior Vice President, Chief Financial Officer (“Employee”).
Severance and Change of Control AgreementSeverance and Change of Control Agreement • March 2nd, 2017 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Cynthia J. Ladd, Senior Vice President, General Counsel (“Employee”).
Severance and Change of Control AgreementSeverance and Change of Control Agreement • May 6th, 2016 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Rachel Humphrey, Senior Vice President, Chief Medical Officer (“Employee”).
